Hypertension Research · 2004 · 64 citations · 28 references
MedicineEndocrinologyPharmacologyBiochemical PharmacologyExperimental PharmacologyMetabolic RegulationDiabetes MellitusDiabetes PharmacotherapyFructose MetabolismInsulin ResistanceLipid-lowering TherapyMetabolic SyndromeAngiotensin Ii Receptor BlockersAntidiabetic Drug TherapyInsulin Resistance TreatmentTriglyceride HomeostasisTriglyceride HydrolysisTriglyceride Synthesis
Although angiotensin II receptor blockers (ARBs) have been recommended as a first line of anti-hypertensive agents in patients with diabetes, it remains unclear whether ARBs have a favorable effect on insulin action and triglyceride (TG) metabolism, both of which are impaired in type 2 diabetes. In this study we addressed this issue by investigating how a newly developed ARB, olmesartan medoxomil, influenced insulin sensitivity and TG metabolism in fructose-fed rats, a representative animal model of insulin resistance. Olmesartan was administrated as a 0.01% drinking solution ad libitum to rats either fed normal chow or fructose-enriched chow (60%) for 21 days. Olmesartan treatment markedly decreased both systolic and diastolic blood pressure in both chow-fed and fructose-fed animals. The area under the curve of insulin (AUCI) was substantially greater in fructose-fed rats in the intravenous glucose tolerance test, and olmesartan treatment significantly reduced the AUCI. Olmesartan significantly improved the insulin sensitivity index in fructose-fed rats assessed by Bergman's minimal model without affecting insulin-independent glucose disposal. Olmesartan significantly decreased plasma TG and non-esterified fatty acid levels in fructose-fed rats without affecting lipoprotein lipase mass. The TG secretion rate determined by the triton WR1339 technique was two-fold higher in fructose-fed rats, but olmesartan restored the TG secretion to a normal rate. Olmesartan did not affect plasma parameters, insulin sensitivity or TG metabolism in chow-fed rats. Olmesartan ameliorates insulin resistance and overproduction of TG in fructose-fed rats, and these effects appear to be independent of its hypotensive action.
28
Selective Angiotensin II Receptor Antagonism Reduces Insulin Resistance in Obese Zucker Rats
Erik J. Henriksen, Stephan Jacob, Tyson R. Kinnick et al. · Hypertension · 2001 · 296 citations · Full text
Angiotensin II–Induced Insulin Resistance Is Associated With Enhanced Insulin Signaling
Takehide Ogihara, Tomoichiro Asano, Katsuyuki Ando et al. · Hypertension · 2002 · 273 citations · Full text
Medicine, Endocrinology, Physiology +15
Jørgen Jeppesen, Clarie B. Hollenbeck, Mingyue Zhou et al. · Arteriosclerosis Thrombosis and Vascular Biology · 1995 · 237 citations · Full text
M. Uehara, Hiroki Kishikawa, S. Isami et al. · Diabetologia · 1994 · 141 citations · Full text
Lipoprotein lipase mass and activity in severe hypertriglyceridemia
Junji Kobayashi, Hideyuki Hashimoto, Isamu Fukamachi et al. · Clinica Chimica Acta · 1993 · 129 citations